CCR5 and stroke disorder: Maraviroc, an antagonist of chemokine receptor CCR5, has been shown to protect the mature neurons bordering the infarct area but not the ischemic core.[28] We found that the expression levels of CCR5 and the three ligands were upregulated in the infarct area after stroke, indicated by Western blotting (Figure4a,b).